Amneal EVP gains shares via RSU vesting
Amneal Pharmaceuticals Executive Vice President Nikita Shah reported multiple equity award vestings and related share withholdings.
Rhea-AI Filing Summary
Amneal Pharmaceuticals Executive Vice President Nikita Shah reported multiple equity award vestings and related share withholdings. On March 3, 2026, performance-based restricted stock units granted in 2023 were certified above target, vesting at 200% of the targeted number and settling into an equal number of Class A shares.
Across March 3–4, 2026, Shah acquired Class A Common Stock through exercises and conversions of restricted stock units and performance-based units, while a portion of the resulting shares was automatically disposed of at prices around $13.30 per share to satisfy tax withholding obligations.
Positive
- None.
Negative
- None.
Insider Trade Summary
508,499 shares exercised/converted
Exercise
15 txns
Insider
Shah Nikita
Role
Executive Vice President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 35,880 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 35,880 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Class A Common Stock | 17,976 | $13.30 | $239K |
| Exercise | Restricted Stock Units | 36,232 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 45,871 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 23,544 | $0.00 | $0.00 |
| Exercise | Performance-Based Restricted Stock Units | 366,972 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 36,232 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Class A Common Stock | 18,502 | $13.31 | $246K |
| Exercise | Class A Common Stock | 45,871 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Class A Common Stock | 22,982 | $13.31 | $306K |
| Exercise | Class A Common Stock | 23,544 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Class A Common Stock | 11,796 | $13.31 | $157K |
| Exercise | Class A Common Stock | 366,972 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Class A Common Stock | 183,853 | $13.31 | $2.45M |
Holdings After Transaction:
Restricted Stock Units — 188,266 contracts (Direct);
Performance-Based Restricted Stock Units — 0 contracts (Direct);
Class A Common Stock — 399,793 shares (Direct)
Footnotes (9)
- F1. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
- F2. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F3. Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
- F4. Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. On March 3, 2023, the Reporting Person was granted performance-based restricted stock units, scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. These units were certified as meeting the performance threshold that resulted in vesting of 200% of the targeted number of restricted stock units and these restricted stock units were deemed earned and vested on March 3, 2026 and settled into shares of Class A Common Stock on a one-for-one basis. Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of these performance-based restricted stock unites. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 5.
- F5. Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of performance-based restricted stock units.
- F6. On March 3, 2022, the reporting person was granted 144,928 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
- F7. On March 3, 2023, the reporting person was granted 183,486 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
- F8. On March 3, 2025, the reporting person was granted 94,178 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
- F9. On March 4, 2024, the reporting person was granted 143,519 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
FAQ
What insider transactions did AMRX executive Nikita Shah report?
Nikita Shah reported vesting and settlement of restricted stock units and performance-based units into Amneal Class A Common Stock, along with share dispositions used to cover tax withholding obligations. These transactions reflect equity compensation mechanics rather than open market stock purchases or sales.
How were performance-based RSUs for AMRX’s Nikita Shah determined and vested?
Performance-based restricted stock units granted on March 3, 2023 vested based on Amneal’s Class A Common Stock achieving specified average closing prices over a three-year period. They were certified as meeting a performance threshold that produced vesting at 200% of the targeted number of units.
What does a Form 4 code F mean in Nikita Shah’s AMRX filing?
In this context, transaction code F means shares of Amneal Class A Common Stock were disposed of to pay tax withholding on vested restricted stock units or performance-based units. The filing notes these were payments of exercise price or tax liability by delivering securities.
AI-generated analysis. How Rhea-AI works. Not financial advice.
